Hyderabad, Feb 16: Sanofi Healthcare India Pvt. Ltd. today announced the expansion of its Global Capability Centre in Hyderabad, with the addition of over 2.7 lakh square feet of state-of-the-art working space within the existing campus in Hitech City. The occasion was graced by Hon’ble Sri Duddilla Sridhar Babu, Minister for IT, Industries and Commerce, Govt. of Telangana along with senior Sanofi executives.
Inaugurated in 2024, Sanofi’s Hyderabad GCC is distinguished by its scale, breadth of expertise, ability to support global end-to-end processes and with capabilities spanning AI, digital health, and intelligent automation. The expansion of the GCC would result in an increased capacity to host up to ~4500 employees from the earlier projected ~2600, making it one of Sanofi’s largest talent concentrations in the world. It would also position the site as one of the top three pharma GCCs in India.
Sanofi’s Global Capability Centres are strategic Hubs across the globe that give the company a competitive edge in delivering best-in-class enterprise solutions. Supported by a multi-hundred-million investment, the expansion of Sanofi’s Hyderabad GCC marks a significant milestone in its commitment to India’s thriving life sciences ecosystem and exceptional talent pool. This strategic growth will create a diverse range of roles spanning research and development, digital innovation, data analytics, medical affairs, people services, finance and procurement services and commercial operations – offering exciting career opportunities for professionals at all levels.
The Hyderabad GCC first started in 2019 with operations focused primarily on Medical Services. It has grown exponentially to now providing several best-in-class services to Sanofi’s global functions and affiliates across the world. This future-forward global hub for talent in Hyderabad is designed to be environmentally sustainable and foster diversity and inclusivity. Sanofi has reimagined the workplace as a hospitality-inspired environment that feels like a home away from home. It promotes collaboration and facilitates well-being and optimal performance to improve processes, eliminate errors and enhance efficiencies across the spectrum of research, discovery, manufacturing and supply activities.
Madeleine Roach, EVP, Head of Business Operations, Sanofi, said,
“As an R&D-driven, AI-powered biopharma company, we never lose sight of what truly drives each of us – improving people’s lives. Our operations at the Hyderabad GCC serve to support critical processes across the drug research, development, manufacturing and access lifecycle. India’s exceptional talent pool in digital innovation, AI, and data science is instrumental in accelerating our transformation and advancing our mission. We look
forward to further growing our capabilities and impact and partnering with Telangana as it continues to set new standards in life sciences innovation and global competitiveness.”
Congratulating Sanofi on the occasion, Chief Minister of Telangana, Sri Revanth Reddy said,
“The expansion of Sanofi’s Global Capability Centre in Hyderabad reflects Telangana’s growing stature as a global hub for innovation-driven life sciences. We are proud that leading R&D-focused, AI-powered biopharma companies like Sanofi are choosing Hyderabad to anchor critical global capabilities. This growth strengthens our vision of creating high-skilled employment, accelerating digital and scientific innovation, and positioning Telangana among the world’s leading life sciences ecosystems.”
Sri D Sridhar Babu, Minister for IT, Industries & Commerce, said while inaugurating the campus, “Sanofi’s expanded GCC underscores Hyderabad’s evolution from a manufacturing base to a strategic innovation and digital powerhouse for global biopharma. With deep capabilities in AI, data analytics, medical affairs, and enterprise operations, this centre represents the next generation of value creation in life sciences. Telangana remains committed to providing world-class infrastructure, policy stability, and talent ecosystems that enable global companies to scale with confidence.”
“We have followed through on our commitment made in 2024 when we opened this campus. This expansion not only strengthens our global capabilities but also reinforces our dedication to empowering the local workforce, fostering innovation, and contributing meaningfully to Hyderabad’s position as a premier destination for pharmaceutical and healthcare excellence,”
Mrinal Duggal, Head of Hyderabad Global Hub, Sanofi.
Sanofi in India
Present in India for nearly seven decades, Sanofi has earned the trust of customers and stakeholders for its commitment to promoting health. As Sanofi chases the miracles of science to improve people’s lives, it continues to engage across the entire health spectrum from prevention with vaccines to wellness, treatment, patient support & capacity building.
Sanofi’s India Charitable Access Program (InCAP) is the country’s longest running humanitarian program providing free treatment to people afflicted with Lysosomal Storage Disorders. Sanofi conducts clinical trials in India, so that the country can have quicker access to the latest from the company’s global pipeline. Sanofi India’s world-class manufacturing site in Goa produces for people in India and 60+ other countries. Sanofi has located one of its global talent hubs in Hyderabad, India, from where wide range of services are provided globally.
Recognized by the Employers Institute’ a global authority that honours excellence in people practices since 2019, Sanofi’s local entities include Sanofi India Limited (SIL – listed entity), and Sanofi Healthcare India Pvt. Ltd.